Aviva PLC Merck & Co., Inc. Transaction History
Aviva PLC
- $36.8 Billion
- Q4 2024
A detailed history of Aviva PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aviva PLC holds 2,200,518 shares of MRK stock, worth $209 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
2,200,518
Previous 2,274,151
3.24%
Holding current value
$209 Million
Previous $258 Million
15.24%
% of portfolio
0.59%
Previous 0.7%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,970Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.5 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.65 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.8 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $240B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...